Literature DB >> 19335102

Effects of anticoagulant on pH, ionized calcium concentration, and agonist-induced platelet aggregation in canine platelet-rich plasma.

Mary Beth Callan1, Frances S Shofer, James L Catalfamo.   

Abstract

OBJECTIVE-To compare effects of 3.8% sodium citrate and anticoagulant citrate dextrose solution National Institutes of Health formula A (ACD-A) on pH, extracellular ionized calcium (iCa) concentration, and platelet aggregation in canine platelet-rich plasma (PRP). SAMPLE POPULATION-Samples from 12 dogs. PROCEDURES-Blood samples were collected into 3.8% sodium citrate (dilution, 1:9) and ACD-A (dilution, 1:5). Platelet function, pH, and iCa concentration were evaluated in PRP. Platelet agonists were ADP, gamma-thrombin, and convulxin; final concentrations of each were 20microm, 100nM, and 20nM, respectively. Washed platelets were used to evaluate effects of varying the pH and iCa concentration. RESULTS-Mean pH and iCa concentration were significantly greater in 3.8% sodium citrate PRP than ACD-A PRP. Platelet aggregation induced by ADP and gamma-thrombin was markedly diminished in ACD-A PRP, compared with results for 3.8% sodium citrate PRP. Anticoagulant had no effect on amplitude of convulxin-induced platelet aggregation. In washed platelet suspensions (pH, 7.4), there were no differences in amplitude of platelet aggregation induced by convulxin or gamma-thrombin at various iCa concentrations. Varying the pH had no effect on amplitude of aggregation induced by convulxin or gamma-thrombin, but the aggregation rate increased with increasing pH for both agonists. CONCLUSIONS AND CLINICAL RELEVANCE-Aggregation of canine platelets induced by ADP and gamma-thrombin was negligible in ACD-A PRP, which suggested an increase in extraplatelet hydrogen ion concentration inhibits signaling triggered by these agonists but not by convulxin. Choice of anticoagulant may influence results of in vitro evaluation of platelet function, which can lead to erroneous conclusions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19335102      PMCID: PMC4166489          DOI: 10.2460/ajvr.70.4.472

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  26 in total

1.  Reversibility of severe metabolic stress in stored platelets after in vitro plasma rescue or in vivo transfusion: restoration of secretory function and maintenance of platelet survival.

Authors:  Henry M Rinder; Edward L Snyder; Jayne B Tracey; Dorothy Dincecco; Chao Wang; Laurence Baril; Christine S Rinder; Brian R Smith
Journal:  Transfusion       Date:  2003-09       Impact factor: 3.157

2.  Fibrinogen and ADP-induced platelet aggregation.

Authors:  J F Mustard; M A Packham; R L Kinlough-Rathbone; D W Perry; E Regoeczi
Journal:  Blood       Date:  1978-08       Impact factor: 22.113

3.  The influence of pH, temperature, and calcium on platelet aggregation: maintenance of environmental pH and platelet function for in vitro studies in plasma stored at 37 degrees C.

Authors:  P Han; N G Ardlie
Journal:  Br J Haematol       Date:  1974-03       Impact factor: 6.998

4.  Change of shape without aggregation caused by ADP in rabbit platelets at low pH.

Authors:  J R McLean; H Veloso
Journal:  Life Sci       Date:  1967-09-15       Impact factor: 5.037

5.  The effect of pH on human platelet aggregation induced by epinephrine and ADP.

Authors:  A B Rogers; R M Des Prez
Journal:  Proc Soc Exp Biol Med       Date:  1972-04

6.  Dosage regimens for citrate anticoagulants.

Authors:  J P Hester; J McCullough; J M Mishler; I O Szymanski
Journal:  J Clin Apher       Date:  1983       Impact factor: 2.821

7.  Defective platelet-fibrinogen interaction in hereditary canine thrombopathia.

Authors:  J L Catalfamo; S L Raymond; J G White; W J Dodds
Journal:  Blood       Date:  1986-06       Impact factor: 22.113

8.  Factors responsible for ADP-induced release reaction of human platelets.

Authors:  J F Mustard; D W Perry; R L Kinlough-Rathbone; M A Packham
Journal:  Am J Physiol       Date:  1975-06

9.  Convulxin induces platelet shape change through myosin light chain kinase and Rho kinase.

Authors:  Silvia Riondino; Pier P Gazzaniga; Fabio M Pulcinelli
Journal:  Eur J Biochem       Date:  2002-12

10.  Shape and functional properties of human platelets washed with acid citrate.

Authors:  H Patscheke
Journal:  Haemostasis       Date:  1981
View more
  7 in total

Review 1.  Platelet-Rich Plasma: A Comprehensive Review of Emerging Applications in Medical and Aesthetic Dermatology.

Authors:  Christopher White; Allyson Brahs; David Dorton; Kristin Witfill
Journal:  J Clin Aesthet Dermatol       Date:  2021-11

2.  Evaluation of cytokine concentrations in a trehalose-stabilised lyophilised canine platelet product: a preliminary study.

Authors:  Robert Goggs; Signe Cremer; Marjory B Brooks
Journal:  Vet Rec Open       Date:  2020-08-07

3.  Comparison of Two Anticoagulants for Pain Associated with Platelet-Rich Plasma Injections.

Authors:  Metin Görgü; Ali Gökkaya; Ali Doğan
Journal:  Aesthetic Plast Surg       Date:  2019-11-13       Impact factor: 2.326

4.  [Standardized management of platelet derivatives for tissue regeneration research and applications].

Authors:  Xingqin Xie; Yi Zhang; Xinxin Zhao; Tongxin Liu; Liping Sun
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2021-03-15

Review 5.  Principles and Methods of Preparation of Platelet-Rich Plasma: A Review and Author's Perspective.

Authors:  Rachita Dhurat; Ms Sukesh
Journal:  J Cutan Aesthet Surg       Date:  2014 Oct-Dec

Review 6.  Platelet Function and Therapeutic Applications in Dogs: Current Status and Future Prospects.

Authors:  Laura Cortese; Pete W Christopherson; Alessandra Pelagalli
Journal:  Animals (Basel)       Date:  2020-01-25       Impact factor: 2.752

7.  A Novel and Convenient Method for the Preparation and Activation of PRP without Any Additives: Temperature Controlled PRP.

Authors:  Lijuan Du; Yong Miao; Xin Li; Panli Shi; Zhiqi Hu
Journal:  Biomed Res Int       Date:  2018-05-13       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.